These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24530416)

  • 1. Anti-diabetic properties of a non-conventional radical scavenger, as compared to pioglitazone and exendin-4, in streptozotocin-nicotinamide diabetic mice.
    Novelli M; Canistro D; Martano M; Funel N; Sapone A; Melega S; Masini M; De Tata V; Pippa A; Vecoli C; Campani D; De Siena R; Soleti A; Paolini M; Masiello P
    Eur J Pharmacol; 2014 Apr; 729():37-44. PubMed ID: 24530416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
    Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
    Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent correction of hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice by a non-conventional radical scavenger.
    Novelli M; Bonamassa B; Masini M; Funel N; Canistro D; De Tata V; Martano M; Soleti A; Campani D; Paolini M; Masiello P
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Aug; 382(2):127-37. PubMed ID: 20512314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone, a PPAR-gamma ligand inhibited the nicotinamide-streptozotocin induced sperm abnormalities in type-2 diabetic Wistar rats.
    Rabbani SI; Devi K; Khanam S
    Pak J Pharm Sci; 2010 Jul; 23(3):326-31. PubMed ID: 20566448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a new delivery system based on solid lipid microparticles for the oral administration of the non-conventional antioxidant IAC on a diabetes mouse model.
    Canistro D; Vivarelli F; Cirillo S; Soleti A; Albertini B; Passerini N; Merizzi G; Paolini M
    J Endocrinol Invest; 2018 Oct; 41(10):1227-1236. PubMed ID: 29511967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exendin-4 improves hepatocyte injury by decreasing proliferation through blocking NGF/TrkA in diabetic mice.
    Gezginci-Oktayoglu S; Sacan O; Yanardag R; Karatug A; Bolkent S
    Peptides; 2011 Feb; 32(2):223-31. PubMed ID: 21055431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats.
    Ozyazgan S; Kutluata N; Afşar S; Ozdaş SB; Akkan AG
    Pharmacology; 2005 Jun; 74(3):119-26. PubMed ID: 15746570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-diabetic effects of electrolyzed reduced water in streptozotocin-induced and genetic diabetic mice.
    Kim MJ; Kim HK
    Life Sci; 2006 Nov; 79(24):2288-92. PubMed ID: 16945392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area.
    Xue S; Wasserfall C; Parker M; McGrail S; McGrail K; Campbell-Thompson M; Schatz DA; Atkinson MA; Haller MJ
    J Diabetes Complications; 2010; 24(3):163-7. PubMed ID: 19217320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase.
    Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
    J Diabetes; 2012 Dec; 4(4):369-77. PubMed ID: 22356440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction contribute to diabetic neurotoxicity induced by streptozocin in mice: protective effect of Urtica dioica and pioglitazone.
    Shokrzadeh M; Mirshafa A; Yekta Moghaddam N; Birjandian B; Shaki F
    Toxicol Mech Methods; 2018 Sep; 28(7):499-506. PubMed ID: 29606029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exendin-4 treatment expands graft beta-cell mass in diabetic mice transplanted with a marginal number of fresh islets.
    Juang JH; Kuo CH; Wu CH; Juang C
    Cell Transplant; 2008; 17(6):641-7. PubMed ID: 18819252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The radical scavenger edaravone counteracts diabetes in multiple low-dose streptozotocin-treated mice.
    Fukudome D; Matsuda M; Kawasaki T; Ago Y; Matsuda T
    Eur J Pharmacol; 2008 Mar; 583(1):164-9. PubMed ID: 18291360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes.
    Diani AR; Sawada G; Wyse B; Murray FT; Khan M
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E116-22. PubMed ID: 14532171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exendin-4 protects hypoxic islets from oxidative stress and improves islet transplantation outcome.
    Padmasekar M; Lingwal N; Samikannu B; Chen C; Sauer H; Linn T
    Endocrinology; 2013 Apr; 154(4):1424-33. PubMed ID: 23471218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administrated rats.
    Kaya-Dagistanli F; Ozturk M
    Acta Histochem; 2013 Jul; 115(6):577-86. PubMed ID: 23351716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats.
    Chaudhry J; Ghosh NN; Roy K; Chandra R
    Life Sci; 2007 Feb; 80(12):1135-42. PubMed ID: 17234217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs.
    Shen X; Li H; Li W; Wu X; Ding X
    Mol Cell Endocrinol; 2012 Nov; 363(1-2):27-35. PubMed ID: 22820128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone improves insulin secretory capacity and prevents the loss of beta-cell mass in obese diabetic db/db mice: Possible protection of beta cells from oxidative stress.
    Ishida H; Takizawa M; Ozawa S; Nakamichi Y; Yamaguchi S; Katsuta H; Tanaka T; Maruyama M; Katahira H; Yoshimoto K; Itagaki E; Nagamatsu S
    Metabolism; 2004 Apr; 53(4):488-94. PubMed ID: 15045697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mogrosides extract from Siraitia grosvenori scavenges free radicals in vitro and lowers oxidative stress, serum glucose, and lipid levels in alloxan-induced diabetic mice.
    Qi XY; Chen WJ; Zhang LQ; Xie BJ
    Nutr Res; 2008 Apr; 28(4):278-84. PubMed ID: 19083420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.